The Coronary Stents Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Coronary Stents Market:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
According to The Business Research Company’s Coronary Stents Global Market Report 2024, The coronary stents market size has grown strongly in recent years. It will grow from $10.22 billion in 2023 to $11.06 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.
The coronary stents market size is expected to see strong growth in the next few years. It will grow to $15.25 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.
The rising prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the coronary stent market going forward. Cardiovascular diseases are a group of disorders of the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. Cardiovascular diseases are rising due to factors like an aging population, an increased prevalence of risk factors such as obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is required for cardiovascular diseases to open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For instance, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. Diabetes is expected to rise by 39.3% to 55 million people, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The most significant increases in cardiovascular diseases are projected for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Therefore, the rising prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary stent market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
The coronary stents market covered in this report is segmented –
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Major companies operating in the coronary stent communication market are developing innovative products, such as drug-eluting stents, to reduce the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents coated with medication designed to prevent the re-narrowing of arteries by releasing drugs gradually over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent stands out due to its enhanced design, new delivery system, and unique size options, specifically engineered to address challenging cases. It retains the specialized coating that reduces the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, backed by over 120 clinical trials involving more than 120,000 patients.
The coronary stents market report table of contents includes:
1. Executive Summary
2. Coronary Stents Market Characteristics
3. Coronary Stents Market Trends And Strategies
4. Coronary Stents Market – Macro Economic Scenario
5. Global Coronary Stents Market Size and Growth
…
32. Global Coronary Stents Market Competitive Benchmarking
33. Global Coronary Stents Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Coronary Stents Market
35. Coronary Stents Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
